Clinical Trial Update: Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating copper-64 DOTA-B-Fab for PET/CT imaging in patients with ovarian and breast cancer; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• Copper-64 DOTA-B-Fab (Cu-64 DOTA-B-Fab)

Snippet

Sponsor: Sanjiv Sam Gambhir | Conditions: Ovarian Carcinoma, Breast Carcinoma | Phase 1 | Status: TERMINATED